Shopping Cart
Remove All
Your shopping cart is currently empty
TC-S 7003 (Lck Inhibitor) is an orally active, selective and potent lymphocyte kinase (Lck) inhibitor with anti-inflammatory activity, inhibition of Lck, Lyn, Src, and Syk kinases, and inhibition of T-cell proliferation, and may be useful in the study of arthritis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $48 | - | In Stock | |
| 5 mg | $116 | - | In Stock | |
| 10 mg | $186 | - | In Stock | |
| 25 mg | $373 | - | In Stock | |
| 50 mg | $618 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $136 | - | In Stock |
| Description | TC-S 7003 (Lck Inhibitor) is an orally active, selective and potent lymphocyte kinase (Lck) inhibitor with anti-inflammatory activity, inhibition of Lck, Lyn, Src, and Syk kinases, and inhibition of T-cell proliferation, and may be useful in the study of arthritis. |
| Targets&IC50 | T cells:0.53 μM, IL-2:0.46 μM |
| In vitro | TC-S 7003 exhibited good potency in the T-cell receptor-induced IL-2 secretion assay (IL- 2) and also inhibited subsequent T-cell proliferation (T-cell prolif.) in the same human T -cells, IL-2, IC50=0.46 μM, T-cell prolif, IC50=0.53 μM. [1] |
| In vivo | A once-daily dose of TC-S 7003 was administered orally at 10, 30, and 60 mg/kg from day 9 to day 17. TC-S 7003 showed a dose-dependent inhibition of arthritis (ED50=24 mg/kg). [1] |
| Synonyms | Lck Inhibitor |
| Molecular Weight | 530.62 |
| Formula | C31H30N8O |
| Cas No. | 847950-09-8 |
| Smiles | O=C1C2=CN=C(N=C2N3C(=NC=4C=CC=CC43)N1C=5C(=CC=CC5C)C)NC6=CC=C(C=C6)N7CCN(C)CC7 |
| Relative Density. | 1.36 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL(150.77 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (6.22 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.